These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 32222729)

  • 1. Investigating the theragnostic potential of
    Zhou YY; Zhang PP; Lin RT; Chen TS; Liu XY; Liu WJ; Liang YN; Chen S; Pan X; Ni GY; Wang TF; Liu XS; Yuan JW
    Hell J Nucl Med; 2020; 23(1):27-33. PubMed ID: 32222729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iodine-125 labeled Australian frog tree host-defense peptides caerin 1.1 and 1.9 better inhibit human breast cancer cells growth than the unlabeled peptides.
    Yuan J; You X; Ni G; Wang T; Cavezza S; Pan X; Liu X
    Hell J Nucl Med; 2018; 21(2):115-120. PubMed ID: 30006645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted radioimmunotherapy with the iodine-131-labeled caerin 1.1 peptide for human anaplastic thyroid cancer in nude mice.
    Lin R; Ma B; Liu N; Zhang L; He T; Liu X; Chen T; Liu W; Liang Y; Wang T; Ni G; Liu X; Yang N; Zhang J; Yuan J
    Ann Nucl Med; 2021 Jul; 35(7):811-822. PubMed ID: 33948902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone deacetylase inhibition affects sodium iodide symporter expression and induces 131I cytotoxicity in anaplastic thyroid cancer cells.
    Pugliese M; Fortunati N; Germano A; Asioli S; Marano F; Palestini N; Frairia R; Boccuzzi G; Catalano MG
    Thyroid; 2013 Jul; 23(7):838-46. PubMed ID: 23531031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reintroducing the Sodium-Iodide Symporter to Anaplastic Thyroid Carcinoma.
    Schmohl KA; Dolp P; Schug C; Knoop K; Klutz K; Schwenk N; Bartenstein P; Nelson PJ; Ogris M; Wagner E; Spitzweg C
    Thyroid; 2017 Dec; 27(12):1534-1543. PubMed ID: 29032724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioiodine as an adjuvant therapy and its role in follow-up of differentiated thyroid cancer.
    Padma S; Sundaram PS
    J Cancer Res Ther; 2016; 12(3):1109-1113. PubMed ID: 28054519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical efficacy of the oncolytic measles virus expressing the sodium iodide symporter in iodine non-avid anaplastic thyroid cancer: a novel therapeutic agent allowing noninvasive imaging and radioiodine therapy.
    Reddi HV; Madde P; McDonough SJ; Trujillo MA; Morris JC; Myers RM; Peng KW; Russell SJ; McIver B; Eberhardt NL
    Cancer Gene Ther; 2012 Sep; 19(9):659-65. PubMed ID: 22790962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental study of
    He T; Du J; Zhu K; Zhou Y; Xiao Z; Liu W; Ren W; Liu X; Chen T; Liu W; Chen Z; Ni G; Liu X; Wang T; Quan J; Zhang P; Yuan J
    Biomed Pharmacother; 2023 Aug; 164():114891. PubMed ID: 37209630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel therapeutic strategy for medullary thyroid cancer based on radioiodine therapy following tissue-specific sodium iodide symporter gene expression.
    Cengic N; Baker CH; Schütz M; Göke B; Morris JC; Spitzweg C
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4457-64. PubMed ID: 15941870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [β-catenin nuclear translocation represses thyroid cancer stem cells differentiating into cells with sodium-iodine symporter functional expression].
    Lan L; Deng W; Cui D; Chen HL; Huo LL; Zuo QY; Li W; Zhang GY; Luo Y
    Zhonghua Yi Xue Za Zhi; 2019 Jun; 99(24):1904-1910. PubMed ID: 31269588
    [No Abstract]   [Full Text] [Related]  

  • 11. Relationship between expression of the sodium/iodide symporter and 131I uptake in recurrent lesions of differentiated thyroid carcinoma.
    Min JJ; Chung JK; Lee YJ; Jeong JM; Lee DS; Jang JJ; Lee MC; Cho BY
    Eur J Nucl Med; 2001 May; 28(5):639-45. PubMed ID: 11383871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cotransfected sodium iodide symporter and human tyroperoxidase genes following human telomerase reverse transcriptase promoter for targeted radioiodine therapy of malignant glioma cells.
    Li W; Tan J; Wang P; Wu P
    Cancer Biother Radiopharm; 2011 Aug; 26(4):443-51. PubMed ID: 21797672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining transfer of TTF-1 and Pax-8 gene: a potential strategy to promote radioiodine therapy of thyroid carcinoma.
    Mu D; Huang R; Li S; Ma X; Lou C; Kuang A
    Cancer Gene Ther; 2012 Jun; 19(6):402-11. PubMed ID: 22498723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced radioiodine-refractory differentiated thyroid cancer: the sodium iodide symporter and other emerging therapeutic targets.
    Spitzweg C; Bible KC; Hofbauer LC; Morris JC
    Lancet Diabetes Endocrinol; 2014 Oct; 2(10):830-42. PubMed ID: 24898835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lithium as adjuvant to radioiodine therapy in differentiated thyroid carcinoma: clinical and in vitro studies.
    Liu YY; van der Pluijm G; Karperien M; Stokkel MP; Pereira AM; Morreau J; Kievit J; Romijn JA; Smit JW
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):617-24. PubMed ID: 16712662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cholesterol-derived metabolite dendrogenin A functionally reprograms breast adenocarcinoma and undifferentiated thyroid cancer cells.
    Bauriaud-Mallet M; Vija-Racaru L; Brillouet S; Mallinger A; de Medina P; Rives A; Payre B; Poirot M; Courbon F; Silvente-Poirot S
    J Steroid Biochem Mol Biol; 2019 Sep; 192():105390. PubMed ID: 31170473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of radioactive astatine and iodine uptake in cancer cell lines expressing the human sodium/iodide symporter.
    Petrich T; Helmeke HJ; Meyer GJ; Knapp WH; Pötter E
    Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):842-54. PubMed ID: 12111124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HMGB1-mediated autophagy regulates sodium/iodide symporter protein degradation in thyroid cancer cells.
    Chai W; Ye F; Zeng L; Li Y; Yang L
    J Exp Clin Cancer Res; 2019 Jul; 38(1):325. PubMed ID: 31331356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iodide uptake and experimental 131I therapy in transplanted undifferentiated thyroid cancer cells expressing the Na+/I- symporter gene.
    Shimura H; Haraguchi K; Miyazaki A; Endo T; Onaya T
    Endocrinology; 1997 Oct; 138(10):4493-6. PubMed ID: 9322970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rat sodium iodide symporter allows using lower dose of 131I for cancer therapy.
    Mitrofanova E; Unfer R; Vahanian N; Link C
    Gene Ther; 2006 Jul; 13(13):1052-6. PubMed ID: 16525480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.